Stock Earnings

Question 1

How did MDNAF's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Medicenna Therapeutics Corp is $-0.06, beating expectations of $-0.05.

Question 2

How did Medicenna Therapeutics Corp MDNAF's revenue perform in the last quarter?

Accepted Answer

Medicenna Therapeutics Corp revenue for the last quarter is $-0.06

Question 3

What is the revenue estimate for Medicenna Therapeutics Corp?

Accepted Answer

According to 4 of Wall street analyst, the revenue estimate of Medicenna Therapeutics Corp range from $0.0 to $0.0

Question 4

What's the earning quality score for Medicenna Therapeutics Corp?

Accepted Answer

Medicenna Therapeutics Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Medicenna Therapeutics Corp report earnings?

Accepted Answer

Medicenna Therapeutics Corp next earnings report is expected in 2025-10-29

Question 6

What are Medicenna Therapeutics Corp's expected earnings?

Accepted Answer

Medicenna Therapeutics Corp expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Medicenna Therapeutics Corp beat earnings expectations?

Accepted Answer

Medicenna Therapeutics Corp recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$-0.05	$-0.06	+20.0%	BEAT
Q4 '25	$-0.06	$0.02	-133.33%	MISSED
Q3 '25	$-0.06	$-0.07	+16.66%	BEAT
Q2 '25	$-0.06	$-0.05	-16.66%	MISSED
Q1 '25	$-0.06	$-0.05	-16.66%	MISSED

Medicenna Therapeutics Corp (MDNAF) Price

MDNAF Stock Price Chart

Latest Earnings Results: Q1 '26

Historical Earnings

Earnings FAQ